PL3324994T3 - Nx-1207 do zastosowania w sposobach zmniejszenia konieczności operacji chirurgicznej u pacjentów cierpiących na łagodny rozrost gruczołu krokowego - Google Patents
Nx-1207 do zastosowania w sposobach zmniejszenia konieczności operacji chirurgicznej u pacjentów cierpiących na łagodny rozrost gruczołu krokowegoInfo
- Publication number
- PL3324994T3 PL3324994T3 PL16750556T PL16750556T PL3324994T3 PL 3324994 T3 PL3324994 T3 PL 3324994T3 PL 16750556 T PL16750556 T PL 16750556T PL 16750556 T PL16750556 T PL 16750556T PL 3324994 T3 PL3324994 T3 PL 3324994T3
- Authority
- PL
- Poland
- Prior art keywords
- surgery
- reducing
- methods
- need
- patients suffering
- Prior art date
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000001356 surgical procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/808,731 US11628202B2 (en) | 2015-07-24 | 2015-07-24 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| EP16750556.9A EP3324994B1 (en) | 2015-07-24 | 2016-07-25 | Nx-1207 for use in methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| PCT/US2016/043850 WO2017019593A1 (en) | 2015-07-24 | 2016-07-25 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3324994T3 true PL3324994T3 (pl) | 2021-08-16 |
Family
ID=56682253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16750556T PL3324994T3 (pl) | 2015-07-24 | 2016-07-25 | Nx-1207 do zastosowania w sposobach zmniejszenia konieczności operacji chirurgicznej u pacjentów cierpiących na łagodny rozrost gruczołu krokowego |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11628202B2 (pl) |
| EP (1) | EP3324994B1 (pl) |
| JP (1) | JP6884134B2 (pl) |
| KR (1) | KR20180037986A (pl) |
| CN (1) | CN108025037A (pl) |
| AU (1) | AU2016297890B2 (pl) |
| BR (1) | BR112018001533A2 (pl) |
| CA (1) | CA2993548A1 (pl) |
| DK (1) | DK3324994T3 (pl) |
| ES (1) | ES2872730T3 (pl) |
| HU (1) | HUE054137T2 (pl) |
| LT (1) | LT3324994T (pl) |
| MX (1) | MX385860B (pl) |
| PL (1) | PL3324994T3 (pl) |
| PT (1) | PT3324994T (pl) |
| SI (1) | SI3324994T1 (pl) |
| WO (1) | WO2017019593A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10532081B2 (en) * | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
| US10835538B2 (en) | 2018-03-28 | 2020-11-17 | Nymox Corporation | Method of treating benign prostatic hyperlasia with antibiotics |
| US20200061150A1 (en) * | 2018-08-23 | 2020-02-27 | Nymox Corporation | Method of inducing selective prostate glandular pharmaco-ablation with sparing of nerves and preservation of sexual function |
| US11278588B2 (en) | 2019-05-13 | 2022-03-22 | Nymox Corporation | Method of treating lower urinary tract symptoms with fexapotide triflutate |
| US20200360466A1 (en) | 2019-05-13 | 2020-11-19 | Nymox Corporation | Method of improving lower urinary tract symptoms |
| US11298400B2 (en) * | 2019-05-13 | 2022-04-12 | Nymox Corporation | Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS |
| US11331374B2 (en) | 2019-07-31 | 2022-05-17 | Nymox Corporation | Focal treatment of prostate cancer |
| US11231421B2 (en) | 2019-07-31 | 2022-01-25 | Nymox Corporation | Methods of treating multifocal cancer |
| AU2023215340A1 (en) * | 2022-02-04 | 2024-09-19 | AecorBio Inc. | Medicinal uses of oligopeptides in combination with an antiandrogen |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948634A (en) | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
| DE68927459T2 (de) | 1988-12-21 | 1997-04-24 | Gen Hospital Corp | Nachweis einer neurologischen Krankheit oder einer Funktionsstörung |
| JPH06256387A (ja) | 1991-06-14 | 1994-09-13 | Suetsuna Yoko | 新規なペプチド、その製法およびそれを有効成分とする 血圧降下剤 |
| DE69434844T2 (de) | 1993-04-20 | 2006-12-14 | The General Hospital Corp., Boston | Geneexpression der neurofilamentproteine und nachweis der alzheimeschen erkrankung |
| ATE229977T1 (de) | 1996-03-26 | 2003-01-15 | Razvan T Radulescu | Peptide mit antiproliferativen eigenschaften |
| KR20000075748A (ko) | 1997-02-26 | 2000-12-26 | 마빈 씨. 구트리 | 알츠하이머 병의 치료 또는 예방에 유효한 약물을 선별하기 위한 유전자 변형동물 및 세포계 |
| WO1999019347A1 (en) | 1997-10-10 | 1999-04-22 | Astrazeneca Ab | Synthetic genes with immunomodulatory effects |
| WO2000034477A2 (en) | 1998-12-11 | 2000-06-15 | Incyte Pharmaceuticals, Inc. | Neuron-associated proteins |
| WO2000058339A2 (en) | 1999-03-26 | 2000-10-05 | Human Genome Sciences, Inc. | 50 human secreted proteins |
| JP2002542766A (ja) | 1999-03-12 | 2002-12-17 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ５０個のヒト分泌タンパク質 |
| AU3628600A (en) | 1999-03-19 | 2000-10-09 | Human Genome Sciences, Inc. | 46 human secreted proteins |
| JP2002541833A (ja) | 1999-03-26 | 2002-12-10 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ４９個のヒト分泌タンパク質 |
| CA2368927A1 (en) | 1999-03-26 | 2000-10-05 | Craig A. Rosen | 45 human secreted proteins |
| CN1300779A (zh) | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽－人神经元线蛋白17和编码这种多肽的多核苷酸 |
| JP2001264442A (ja) * | 2000-03-22 | 2001-09-26 | Fuji Photo Film Co Ltd | 画像記録媒体 |
| EP1307488A2 (en) | 2000-06-26 | 2003-05-07 | Millennium Pharmaceuticals, Inc. | A human calcium channel protein and uses thereof |
| US7259232B1 (en) | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
| CA2325666A1 (fr) | 2000-12-01 | 2002-06-01 | Institut Pasteur | Peptides immunogeniques mutes derives de r9m, polynucleotides les codants et leurs usages therapeutiques |
| US6783969B1 (en) | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
| BR0207638A (pt) | 2001-03-08 | 2004-07-27 | Nymox Pharmaceuticals Corp | Métodos de uso de proteìna de filamento neural para tratar tumores e outras condições que requerem a remoção ou destruição de células |
| DE60205366T2 (de) | 2001-05-16 | 2006-05-24 | Nymox Corp., Saint-Laurent | Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine |
| WO2002097030A2 (en) | 2001-05-25 | 2002-12-05 | Nymox Corporation | Peptides derived from neural thread proteins and their medical use |
| JP4587667B2 (ja) | 2001-07-19 | 2010-11-24 | ナイモックス コーポレーション | 細胞の除去又は破壊を必要とする腫瘍及び他の状態の治療に有効なペプチド |
| US7317077B2 (en) | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US7642063B2 (en) | 2004-05-19 | 2010-01-05 | Auburn University | Methods for targeting and killing glioma cells |
| PL1994152T3 (pl) | 2006-02-28 | 2013-05-31 | Nymox Corp | Peptydy skuteczne w leczeniu nowotworów i innych stanów wymagających usunięcia lub zniszczenia komórek |
| MX2008011570A (es) | 2006-03-10 | 2008-09-23 | Nymox Corp | Metodo para prevenir o reducir el riesgo o incidencia de cancer usando peptidos basados en proteina de hebra neural. |
| US9243035B2 (en) | 2013-11-26 | 2016-01-26 | Nymox Corporation | Peptides effective in the treatment of conditions requiring the removal or destruction of cells |
| US20160215031A1 (en) | 2015-01-27 | 2016-07-28 | Nymox Pharnaceutical Corporation | Method of treating disorders requiring destruction or removal of cells |
| JP6256387B2 (ja) | 2015-03-09 | 2018-01-10 | 株式会社豊田自動織機 | 電動圧縮機 |
| US20160361380A1 (en) | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
-
2015
- 2015-07-24 US US14/808,731 patent/US11628202B2/en active Active
-
2016
- 2016-07-25 EP EP16750556.9A patent/EP3324994B1/en active Active
- 2016-07-25 LT LTEP16750556.9T patent/LT3324994T/lt unknown
- 2016-07-25 DK DK16750556.9T patent/DK3324994T3/da active
- 2016-07-25 MX MX2018001052A patent/MX385860B/es unknown
- 2016-07-25 KR KR1020187005038A patent/KR20180037986A/ko not_active Ceased
- 2016-07-25 CA CA2993548A patent/CA2993548A1/en active Pending
- 2016-07-25 BR BR112018001533-4A patent/BR112018001533A2/pt not_active Application Discontinuation
- 2016-07-25 WO PCT/US2016/043850 patent/WO2017019593A1/en not_active Ceased
- 2016-07-25 JP JP2018503141A patent/JP6884134B2/ja not_active Expired - Fee Related
- 2016-07-25 ES ES16750556T patent/ES2872730T3/es active Active
- 2016-07-25 HU HUE16750556A patent/HUE054137T2/hu unknown
- 2016-07-25 AU AU2016297890A patent/AU2016297890B2/en not_active Ceased
- 2016-07-25 CN CN201680053923.0A patent/CN108025037A/zh active Pending
- 2016-07-25 PT PT167505569T patent/PT3324994T/pt unknown
- 2016-07-25 SI SI201631162T patent/SI3324994T1/sl unknown
- 2016-07-25 PL PL16750556T patent/PL3324994T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3324994B1 (en) | 2021-04-14 |
| SI3324994T1 (sl) | 2021-08-31 |
| AU2016297890A1 (en) | 2018-02-15 |
| EP3324994A1 (en) | 2018-05-30 |
| BR112018001533A2 (pt) | 2019-02-12 |
| LT3324994T (lt) | 2021-05-25 |
| US20170020957A1 (en) | 2017-01-26 |
| WO2017019593A1 (en) | 2017-02-02 |
| HK1249007A1 (zh) | 2018-10-26 |
| DK3324994T3 (da) | 2021-04-26 |
| MX385860B (es) | 2025-03-04 |
| AU2016297890B2 (en) | 2021-08-19 |
| JP2018520200A (ja) | 2018-07-26 |
| ES2872730T3 (es) | 2021-11-02 |
| CA2993548A1 (en) | 2017-02-02 |
| CN108025037A (zh) | 2018-05-11 |
| US11628202B2 (en) | 2023-04-18 |
| MX2018001052A (es) | 2018-11-09 |
| JP6884134B2 (ja) | 2021-06-09 |
| HUE054137T2 (hu) | 2021-08-30 |
| PT3324994T (pt) | 2021-05-25 |
| KR20180037986A (ko) | 2018-04-13 |
| NZ739292A (en) | 2024-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3324994T3 (pl) | Nx-1207 do zastosowania w sposobach zmniejszenia konieczności operacji chirurgicznej u pacjentów cierpiących na łagodny rozrost gruczołu krokowego | |
| IL272948A (en) | ENPP1 inhibitors and their use for cancer treatment | |
| IL258854A (en) | Preparations containing cannabidiol and secondary medicinal agents for cancer treatment | |
| ZA201902320B (en) | 17alpha,21-diesters of cortexolone for use in the treatment of tumors | |
| ZA201900960B (en) | Methods and compositions for the treatment of cancer | |
| GB201717123D0 (en) | Surgical tables and methods of operating the same | |
| IL247586A0 (en) | Use of Aribolin and mtor inhibitors as a combined treatment for cancer | |
| ZA201808232B (en) | Compositions and methods for the treatment of cancer | |
| PL3302523T3 (pl) | Kompozycja do leczenia zmian tkankowych | |
| ZA201900984B (en) | Methods and compositions for the treatment of warts | |
| ZA201708608B (en) | Il-8 inhibitors for use in the treatment of certain urological disorders | |
| IL273863B1 (en) | Hemorrhoid treatment device | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| SG11202000724XA (en) | Methods and compositions for the treatment of cancer | |
| EP3250558A4 (en) | Hypdh inhibitors and methods of use for the treatment of kidney stones | |
| PT3128938T (pt) | Dispositivo bipolar para a ressecção cirúrgica de tecidos | |
| GB201621183D0 (en) | Clopidogrel for use in the treatment of benign prostatic hyperplasia | |
| HK1247853A1 (en) | Il-8 inhibitors for use in the treatment of certain urological disorders | |
| GB201523005D0 (en) | The traditional chinese medicine combination for the treatment of bone hyperplasia | |
| GB201403086D0 (en) | Selection of virus and agent useful in the treatment of cancer |